Igm Financial Inc (IGIFF) 27.8000 $IGIFF IGM Financial

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Igm Financial Inc (IGIFF) 27.8000 $IGIFF

IGM Financial Inc. Added to FTSE4Good Index Series
Marketwire Canada - Fri Jul 22, 10:54AM CDT
WINNIPEG, MANITOBA--(Marketwired - Jul 22, 2016) - IGM Financial Inc. (TSX:IGM) has been added to the FTSE4Good Index Series.
IGM.TO: 36.53 (-0.25)

IGM Financial Inc. Named One of Canada's 50 Best Corporate Citizens
Marketwired - Fri Jun 10, 9:01AM CDT
WINNIPEG, MANITOBA--(Marketwired - Jun 10, 2016) - IGM Financial Inc. (TSX:IGM) has been ranked among Corporate Knights' 15th Annual Best 50 Corporate Citizens in Canada.
IGM.TO: 36.53 (-0.25)

Media Advisory: IGM Financial Inc. to Release Second Quarter 2016 Results
Marketwire Canada - Fri Jun 03, 8:01AM CDT
WINNIPEG, MANITOBA--(Marketwired - Jun 3, 2016) - The news release announcing IGM Financial Inc.'s (TSX:IGM) second quarter 2016 results will be issued on Thursday, August 4, 2016.
IGM.TO: 36.53 (-0.25)

IGM Financial Inc. Announces May 2016 Mutual Fund Sales and Total Assets Under Management
Marketwire Canada - Thu Jun 02, 12:51PM CDT
WINNIPEG, MANITOBA--(Marketwired - Jun 2, 2016) - IGM Financial Inc. (IGM) (TSX:IGM) today reported preliminary total mutual fund net new money in May of ($186.8) million as shown in Table 1. Total assets under management were $135.1 billion at May 31, 2016, compared with $132.4 billion at April 30, 2016 and $148.5 billion at May 31, 2015. Mutual fund assets under management were $129.8 billion as at May 31, 2016, compared with $127.0 billion at April 30, 2016 and $131.6 billion at May 31, 2015. Assets under management are shown in Table 2.
IGM.TO: 36.53 (-0.25)

IGM Financial Inc. Invests in Market-Leading U.S. Digital Wealth Advisor Personal Capital
Marketwired - Thu May 19, 6:31AM CDT
WINNIPEG, MANITOBA--(Marketwired - May 19, 2016) - IGM Financial Inc. (TSX:IGM) has closed a $50 million (U.S.) investment in Personal Capital Corporation, a market-leading digital wealth advisor based in the U.S., with an agreement to invest an additional $25 million (U.S.) in the next year for a total of $75 million (U.S.). This would result in an initial 10% ownership stake increasing to 15% within 12 months, with the remaining interest owned by Personal Capital's management team and existing investors.
IGM.TO: 36.53 (-0.25)

Personal Capital Raises $75 Million in Series E Funding
PR Newswire - Thu May 19, 6:30AM CDT
Personal Capital, the leading digital wealth management firm, today announced IGM Financial Inc., a member of the Power Financial Corporation group of companies, has invested $50 million this week, with an agreement to invest another $25 million in the next year. This investment enables IGM Financial the opportunity to participate in the emerging digital wealth management industry in the United States.

IGM Financial Inc. Announces Election of Directors
Marketwire Canada - Fri May 06, 12:38PM CDT
WINNIPEG, MANITOBA--(Marketwired - May 6, 2016) - In accordance with the Toronto Stock Exchange Company Manual, IGM Financial Inc. (TSX:IGM) is issuing this news release to disclose that the nominees listed in its management proxy circular dated February 29, 2016, with the exception of two who did not stand for election at the Annual Meeting of Shareholders, were elected as its directors. The detailed results of the vote at its Annual Meeting of Shareholders held earlier today in Winnipeg, Manitoba are set out below.
IGM.TO: 36.53 (-0.25)

IGM Financial Inc. Reports First Quarter Earnings
Marketwire Canada - Fri May 06, 9:24AM CDT
WINNIPEG, MANITOBA--(Marketwired - May 6, 2016) - Readers are referred to the disclaimer regarding Forward-Looking Statements and Additional IFRS Measures at the end of this Release.
IGM.TO: 36.53 (-0.25)

Barry McInerney Named President and Chief Executive Officer of Mackenzie Investments
Marketwired - Thu May 05, 2:01PM CDT
WINNIPEG, MANITOBA--(Marketwired - May 5, 2016) - The Board of Directors of IGM Financial Inc. (IGM) (TSX:IGM) announced today that they have appointed Mr. Barry McInerney as President and Chief Executive Officer of Mackenzie Investments, effective May 6, 2016.
IGM.TO: 36.53 (-0.25)

IGM Financial Inc. Announces April 2016 Mutual Fund Sales and Total Assets Under Management
Marketwired - Tue May 03, 11:33AM CDT
IGM Financial Inc. (IGM) (TSX: IGM) today reported preliminary total mutual fund net new money in April of ($262.3) million as shown in Table 1. Total assets under management were $132.4 billion at April 30, 2016, compared with $132.9 billion at March 31, 2016 and $147.6 billion at April 30, 2015. Mutual fund assets under management were $127.0 billion as at April 30, 2016, compared with $127.1 billion at March 31, 2016 and $130.7 billion at April 30, 2015. Assets under management are shown in Table 2.
IGM.TO: 36.53 (-0.25)

IGM Financial Inc. Announces March 2016 Mutual Fund Sales and Total Assets Under Management
Marketwired - Mon Apr 04, 1:00PM CDT
IGM Financial Inc. (IGM) (TSX: IGM) today reported preliminary total mutual fund net new money in March of $77.7 million as shown in Table 1. Total assets under management were $132.9 billion at March 31, 2016, compared with $129.0 billion at February 29, 2016 and $148.4 billion at March 31, 2015. Mutual fund assets under management were $127.1 billion as at March 31, 2016, compared with $123.1 billion at February 29, 2016 and $131.5 billion at March 31, 2015. Assets under management are shown in Table 2.
IGM.TO: 36.53 (-0.25)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 314

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 187

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 129

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 287

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Kearney's 2025 Global Cities Report Insights

Updated Category News Views 654

Global Cities Adapt to New Challenges and Emergence Global cities hold steady at the top as new hubs surge forward Top cities reaffirm their dominance in the Global Cities Index, showcasing remarkable resilience amidst global changes and uncertainties. The Global Cities Outlook indicates a noticeable shift as traditional leaders face turbulence, while emerging Gulf and...

Continue Reading
Vacca Family Law Group Enhances Support for Peaceful Divorce

Updated Category News Views 255

Empowering Families Through Non-Adversarial Divorce Solutions Families navigating the challenging process of separation now have renewed access to considerate and non-confrontational divorce options. Vacca Family Law Group has recently welcomed Attorney and Mediator Wendy Reimer, who brings nearly two decades of experience in family law and a strong background in...

Continue Reading
Ingredion Delivers Impressive Q3 Results, Upgrades Outlook

Updated Category News Views 55

Ingredion's Strong Performance in the Third Quarter Ingredion Incorporated (NYSE: INGR) has reported remarkable results for the third quarter of 2024, showcasing a noteworthy surge in both operating income and earnings per share (EPS). The global leader in ingredient solutions for the food and beverage industry achieved a stunning 26% increase in reported operating income...

Continue Reading
Insight into Learning Technologies Group Plc's Disclosure Mechanism

Updated Category News Views 193

Understanding the Public Opening Position Disclosure Process In the complex world of financial securities, understanding the disclosure requirements can feel daunting. However, the process outlined by the Takeover Code, particularly Rule 8.3, provides a structured approach for individuals and entities holding significant interests in relevant securities. This rule is...

Continue Reading
Avidity Biosciences Set to Inspire with Latest Presentations

Updated Category News Views 191

Avidity Biosciences' Key Presentations at the MDA Conference Avidity Biosciences, Inc. (Nasdaq: RNA), a pioneer in RNA therapeutics, is poised to make a significant impact at the upcoming Clinical and Scientific Conference organized by the Muscular Dystrophy Association (MDA). The event will showcase the latest advancements in the field and highlight groundbreaking...

Continue Reading